Q1 2020 Ultragenyx Pharmaceutical Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Ultragenyx First Quarter 2020 Financial Results Conference Call. (Operator Instructions)
Please be advised that today's conference may be recorded. (Operator Instructions) I would now like to hand the call over to your speaker today, Ms. Danielle Keatley. Please go ahead.
Good afternoon, and welcome to the Ultragenyx Pharmaceutical Financial Results and Corporate Update Conference Call for the first quarter 2020. We have issued a press release detailing our financial results, which you can find on our website at ultragenyx.com.
I am Danielle Keatley, Senior Director of Investor Relations. Joining me on this call are Emil Kakkis, Chief Executive Officer and President; Shalini Sharp, Chief Financial Officer; Camille Bedrosian, Chief Medical Officer; and Erik Harris, Chief Commercial Officer.
I would like to remind investors that this call will include forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |